51 related articles for article (PubMed ID: 38678107)
21. Acute Kidney Injury Following High-Dose Methotrexate Administration in a Day Care Hospital.
Misra SC; Santagostino A; Dine G; Bonhomme Faivre L
Drug Saf Case Rep; 2019 Nov; 6(1):12. PubMed ID: 31713725
[TBL] [Abstract][Full Text] [Related]
22. Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population.
Lv S; Fan H; Li J; Yang H; Huang J; Shu X; Zhang L; Xu Y; Li X; Zuo J; Xiao C
Front Pharmacol; 2018; 9():1390. PubMed ID: 30546311
[No Abstract] [Full Text] [Related]
23. Preventing and Managing Toxicities of High-Dose Methotrexate.
Howard SC; McCormick J; Pui CH; Buddington RK; Harvey RD
Oncologist; 2016 Dec; 21(12):1471-1482. PubMed ID: 27496039
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232.
Larsen EC; Devidas M; Chen S; Salzer WL; Raetz EA; Loh ML; Mattano LA; Cole C; Eicher A; Haugan M; Sorenson M; Heerema NA; Carroll AA; Gastier-Foster JM; Borowitz MJ; Wood BL; Willman CL; Winick NJ; Hunger SP; Carroll WL
J Clin Oncol; 2016 Jul; 34(20):2380-8. PubMed ID: 27114587
[TBL] [Abstract][Full Text] [Related]
25. Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.
Ghodke-Puranik Y; Puranik AS; Shintre P; Joshi K; Patwardhan B; Lamba J; Niewold TB; Chopra A
Pharmacogenomics; 2015 Dec; 16(18):2019-34. PubMed ID: 26616421
[TBL] [Abstract][Full Text] [Related]
26. Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.
den Hoed MA; Lopez-Lopez E; te Winkel ML; Tissing W; de Rooij JD; Gutierrez-Camino A; Garcia-Orad A; den Boer E; Pieters R; Pluijm SM; de Jonge R; van den Heuvel-Eibrink MM
Pharmacogenomics J; 2015 Jun; 15(3):248-54. PubMed ID: 25348617
[TBL] [Abstract][Full Text] [Related]
27. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.
Suthandiram S; Gan GG; Zain SM; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Pharmacogenomics; 2014 Aug; 15(11):1479-94. PubMed ID: 25303299
[TBL] [Abstract][Full Text] [Related]
28. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.
Jacobson PA; Schladt D; Israni A; Oetting WS; Lin YC; Leduc R; Guan W; Lamba V; Matas AJ;
Transplantation; 2012 Mar; 93(6):624-31. PubMed ID: 22334041
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia.
Salazar J; Altés A; del Río E; Estella J; Rives S; Tasso M; Navajas A; Molina J; Villa M; Vivanco JL; Torrent M; Baiget M; Badell I
Pharmacogenomics J; 2012 Oct; 12(5):379-85. PubMed ID: 21747412
[TBL] [Abstract][Full Text] [Related]
30. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
[TBL] [Abstract][Full Text] [Related]
31. PharmGKB summary: methotrexate pathway.
Mikkelsen TS; Thorn CF; Yang JJ; Ulrich CM; French D; Zaza G; Dunnenberger HM; Marsh S; McLeod HL; Giacomini K; Becker ML; Gaedigk R; Leeder JS; Kager L; Relling MV; Evans W; Klein TE; Altman RB
Pharmacogenet Genomics; 2011 Oct; 21(10):679-86. PubMed ID: 21317831
[No Abstract] [Full Text] [Related]
32. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
33. Advances in individual prediction of methotrexate toxicity: a review.
Schmiegelow K
Br J Haematol; 2009 Sep; 146(5):489-503. PubMed ID: 19538530
[TBL] [Abstract][Full Text] [Related]
34. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
[No Abstract] [Full Text] [Related]
35. Drug-induced crystal nephropathy: an update.
Yarlagadda SG; Perazella MA
Expert Opin Drug Saf; 2008 Mar; 7(2):147-58. PubMed ID: 18324877
[TBL] [Abstract][Full Text] [Related]
36. [Japanese translation of common terminology criteria for adverse events (CTCAE), and instructions and guidelines].
Int J Clin Oncol; 2004 Dec; 9 Suppl 3():1-82. PubMed ID: 15818867
[No Abstract] [Full Text] [Related]
37. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia.
de Jonge R; Hooijberg JH; van Zelst BD; Jansen G; van Zantwijk CH; Kaspers GJ; Peters GJ; Ravindranath Y; Pieters R; Lindemans J
Blood; 2005 Jul; 106(2):717-20. PubMed ID: 15797993
[TBL] [Abstract][Full Text] [Related]
38. Genetics of hyperhomocysteinaemia in cardiovascular disease.
Lievers KJ; Kluijtmans LA; Blom HJ
Ann Clin Biochem; 2003 Jan; 40(Pt 1):46-59. PubMed ID: 12542910
[TBL] [Abstract][Full Text] [Related]
39. Prediction of creatinine clearance from serum creatinine.
Cockcroft DW; Gault MH
Nephron; 1976; 16(1):31-41. PubMed ID: 1244564
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
